Avian Influenza: Information for Health Professionals and Laboratorians

• Interim Guidance on Testing, Specimen Collection, and Processing for Patients with Suspected Infection with Novel Influenza A Viruses with the Potential to Cause Severe Disease in Humans
• Interim Guidance for Specimen Collection, Processing, and Testing for Patients with Suspected Infection with Novel Influenza A Viruses Associated with Severe Disease in Humans
• Diagnostics for Detecting H7N9 Using rRT-PCR
• CDC and USDA Interim Risk Assessment and Biosafety Level Recommendations for Working With Influenza A(H7N9) Viruses
• World Health Organization (WHO) Laboratory biorisk management for laboratories handling human specimens suspected or confirmed to contain avian influenza A(H7N9) virus causing human disease Interim recommendations [PDF, 74 KB]

• Interim Guidance for Infection Control Within Healthcare Settings When Caring for Confirmed Cases, Probable Cases, and Cases Under Investigation for Infection with Novel Influenza A Viruses Associated with Severe Disease

Treatment

• Interim Guidance on the Use of Antiviral Medications for Treatment of Human Infections with Novel Influenza A Viruses Associated with Severe Human Disease

Chemoprophylaxis of Persons with Bird Exposure

• Interim Guidance on Influenza Antiviral Chemoprophylaxis of Persons Exposed to Birds with Avian Influenza A Viruses Associated with Severe Human Disease or with the Potential to Cause Severe Human Disease

Chemoprophylaxis of Close Contacts

• Interim Guidance on Follow-up of Close Contacts of Persons Infected with Novel Influenza A Viruses Associated with Severe Human Disease and on the Use of Antiviral Medications for Chemoprophylaxis

HPAI H5 Viruses in U.S. Birds

• Interim Guidance on Case Definitions for Investigations of Human Infection with Highly Pathogenic Avian Influenza A H5 Viruses in the United States July 13, 2015

H5N1

• Interim Guidance on Case Definitions for Investigations of Human Infection with Highly Pathogenic Avian Influenza A (H5N1) Virus in the United States January 13, 2014

H7N9

• Interim Guidance on Case Definitions for Investigations of Human Infection with Avian Influenza A (H7N9) Virus in the United States January 13, 2014

• Bird Infections with Highly-Pathogenic Avian Influenza A (H5N2), (H5N8), and (H5N1) Viruses: Recommendations for Human Health Investigations and Response June 2, 2015

H5N1

• Human Infection with Avian Influenza A (H5N1) Virus January 15, 2014

H7N9

• CDC Health Alert Network (HAN) Update, Human Infections with Avian Influenza A (H7N9) Viruses June 7, 2013
• CDC Health Alert Network (HAN) Human Infections with Novel Influenza A (H7N9) Viruses April 5, 2013

H5N1

• Candidate vaccine viruses and potency testing reagents for influenza A (H5N1), WHO
• Making a Candidate Vaccine Virus (CVV) for a Highly Pathogenic Avian Influenza (Bird Flu) Virus

H7N9

• Summary of status of development and availability of avian influenza A(H7N9) candidate vaccine viruses, WHO
• Update of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza vaccines against avian influenza A(H7N9) virus [PDF, 604 KB]

Title: The New Avian Influenza A (H7N9) Virus: What Clinicians Should Know
Posting Date: Thursday, May 09, 2013
Faculty: Alicia M. Fry, MD, MPH